List of Studies ( Metabolite:Dopamine quinone)
Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Units(range) |
---|---|---|---|---|---|---|---|
ST001788 | AN002899 | β-Adrenergic regulation of metabolism in macrophages (part-IV) | Macrophages | Human | Monash University | Intensity | |
ST002010 | AN003276 | Chemoresistant Ovarian Cancer Global Metabolomics | Cultured cells | Human | Cancer | The University of South Australia | Intensity |
ST000148 | AN000235 | A549 13C-labeled Cell Study | Epithelial cells | Human | Cancer | University of Kentucky | normalized corrected peak area |
ST000142 | AN000225 | H1299 13C-labeled Cell Study | Lung | Human | Cancer | University of Kentucky | Peak area |
ST002237 | AN003650 | Metabolomic analysis of brain cortex from neuronal specific Depdc5 knockout in fed and fasting state | Brain | Mouse | Northwestern University Feinberg School of Medicine | Peak area | |
ST002935 | AN004814 | Title: Myeloid cell-derived creatine in the hypoxic niche promotes glioblastoma growth | Brain | Human | Cancer | Northwestern University, Feinberg School of Medicine | Peak Area |
ST002104 | AN003439 | Chemoresistant Cancer Cell Lines are Characterized by Migratory, Amino Acid Metabolism, Protein Catabolism and IFN1 Signalling Perturbations | Cultured cells | Human | Cancer | Future Industries Institute | peak height |
ST000403 | AN000642 | Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes | Cells | Human | Monash Institute of Pharmaceutical Sciences, Monash University | Peak height | |
ST000539 | AN000818 | Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes (part II) | Cells | Human | Monash Institute of Pharmaceutical Sciences, Monash University | Peak height | |
ST001549 | AN002580 | β-Adrenergic regulation of metabolism in macrophages (part-III) | Macrophages | Human | Monash University | Peak intensity | |
ST002094 | AN003420 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | raw intensity |
ST002094 | AN003421 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | raw intensity |